UK HRT shortages: which products are affected and what to do about it?
Summary
Women in the UK are facing shortages of some hormone replacement therapy (HRT) products used to manage menopause symptoms. Key patches like FemSeven Conti and Estradot are out of stock, with shortages expected to last for weeks or months, and alternatives are available but not always easy to substitute.Key Facts
- HRT helps manage menopause symptoms by replacing hormones like oestrogen and progestogen.
- Nearly 2 million women in England over age 40 were prescribed HRT in 2025-26.
- FemSeven Conti patches, containing estradiol and levonorgestrel, are out of stock until late November.
- Estradot patches, containing estradiol, have had shortages since December 2024, expected to last until January.
- Some HRT products are specialized and cannot always be substituted easily with others.
- Alternatives include other estradiol patches like Evorel Conti and Estradot Conti variants with different progestogens.
- Women experiencing shortages are advised to consult their healthcare provider and not to alter their treatment without medical advice.
- Experts warn shortages may continue due to increasing demand and call for government action to address supply issues.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
